MyAverix Finance
SHG · Healthcare
Dizal (Jiangsu) Pharmaceutical Co. Ltd. A (688192)
Drug Manufacturers - Specialty & Generic
Dizal (Jiangsu) Pharmaceutical Co. Ltd. A (688192) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $26.02B, P/E ratio is 18.00, net margin is -95.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688192
Dizal (Jiangsu) Pharmaceutical Co. Ltd. A (688192) — FAQ
What is Dizal (Jiangsu) Pharmaceutical Co. Ltd. A's market cap?
Dizal (Jiangsu) Pharmaceutical Co. Ltd. A (688192) has a reported market cap of $26.02B (data as of 2026-03-29).
What is 688192's P/E ratio?
The price-to-earnings (P/E) ratio for Dizal (Jiangsu) Pharmaceutical Co. Ltd. A (688192) is 18.00 (data as of 2026-03-29).
Does Dizal (Jiangsu) Pharmaceutical Co. Ltd. A pay a dividend?
Dividend yield is not available in the current snapshot for Dizal (Jiangsu) Pharmaceutical Co. Ltd. A (688192). Check the MyAverix Finance app for the latest dividend data.
What sector is Dizal (Jiangsu) Pharmaceutical Co. Ltd. A in?
Dizal (Jiangsu) Pharmaceutical Co. Ltd. A (688192) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 688192 listed on?
688192 is listed on SHG.
What is Dizal (Jiangsu) Pharmaceutical Co. Ltd. A's net margin?
Dizal (Jiangsu) Pharmaceutical Co. Ltd. A (688192) reports a net margin of -95.3% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.